Huadong Medicine (SHE:000963) subsidiary Sino-US Huadong secured a drug registration from the National Medical Products Administration for its somituximab injection.
Somituximab is used for treating ovarian, fallopian tube and peritoneal cancers, according to a Thursday filing with the Shenzhen Stock Exchange.
Huadong Medicine's shares were up 2% in recent trading.